Rheumatoid Arthritis (RA) Clinical Trials

Find Rheumatoid Arthritis (RA) Clinical Trials Near You

Physical Activity, Sleep and Sedentary Behavior on Atherosclerotic Risk Outcomes Among People With Rheumatoid Arthritis

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

This observational study aims to investigate how 24-hour movement behaviors are associated with atherosclerotic risk in adults with rheumatoid arthritis. These behaviors include physical activity, sedentary behavior, and sleep. The main questions it aims to answer are: * Are 24-hour movement behaviors, both individually and in combination, associated with indicators of atherosclerotic risk in adults with RA? * Do changes in 24-hour movement behaviors over 12 months relate to changes in indicators of atherosclerotic risk? Participants will: * Wear activity monitors (accelerometers) continuously for 7 days to measure physical activity, sedentary behavior, and sleep. * Answer questionnaires about their health and lifestyle. * Undergo cardiovascular assessments, body composition measurements, physical fitness tests, and blood tests to measure lipid and inflammatory profile. * Return 12 months later for follow-up assessments. The researchers hope this study will improve understanding of how daily movement behaviors influence cardiovascular health in people with rheumatoid arthritis. The findings may help inform future recommendations to promote healthier movement behaviors and improve cardiovascular risk management in this population.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 65
Healthy Volunteers: f
View:

• Medical diagnosis of rheumatoid arthritis.

• Age between 18 and 65 years.

• Provide written informed consent.

• Independence in daily living activities defined as a Katz Index score of 5 or 6 points.

Locations
Other Locations
Brazil
Sao Paulo State University
RECRUITING
Presidente Prudente
Contact Information
Primary
William R Tebar, PhD
w.tebar@unesp.br
551832295729
Backup
William R Tebar, PhD
w.tebar@unesp.br
55183229-5729
Time Frame
Start Date: 2026-09-01
Estimated Completion Date: 2028-06-30
Participants
Target number of participants: 150
Related Therapeutic Areas
Sponsors
Leads: São Paulo State University

This content was sourced from clinicaltrials.gov